the role of pacritinib in managing thrombocytopenia in patients with myelofibrosis
Published 2 years ago • 84 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:15
potential approval of pacritinib for the treatment of myelofibrosis
-
1:46
the efficacy of pacritinib in patients with myelofibrosis who have both thrombocytopenia and anemia
-
2:13
current and emerging treatment options for patients with mf who are ineligible for ruxolitinib
-
4:48
an insight into the management of cytopenias in mf
-
1:45
design and results of pacritinib for myelofibrosis trial (persist-1)
-
4:44
keynote-183 and optimismm: creating new standards of care for r/r mm
-
1:05
the future of managing precursor conditions
-
1:00:29
penyakit autoimun darah dengan penurunan trombosit dan bercak merah di kuli itp
-
1:06:04
itp: novel treatments
-
4:59
blood products
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
4:35
pacritinib moving forwards for myelofibrosis
-
3:46
results of the phase iii persist-1 trial of pacritinib for myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:11
the therapeutic implications of shared pathophysiology in classical itp and other thrombocytopenias
-
0:57
the potential of the tsafinder tool in hematological oncology
-
1:41
developing novel gene therapy approaches for hemoglobinopathies
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
1:10
the ecpc and the importance of patient input in clinical research